Deerfield Private Design Fund III, L.P.
Insider CIK 1603333 · LUMO 10% owner · ALIM 10% owner · AERI 10% owner · LIFE 10% owner · XERS 10% owner · PRTO 10% owner · LRMR Director, 10% owner · NEOS 10% owner · AAVL 10% owner · CTMX 10% owner · AFIB Director, 10% owner · GRAY 10% owner · SYRS 10% owner · GUTS 10% owner · RGNX 10% owner · STDY 10% owner · BOLD 10% owner · SWAV 10% owner · RYTM 10% owner · EDIT 10% owner · AVXS 10% owner · ARVN 10% owner · PBLS 10% owner · FIXX Director, 10% owner · ONCR Director, 10% owner · SPRY 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 246,732 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 246,732 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 464,550 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 464,550 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 143,650 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 166,070 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 166,070 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 143,650 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 149,238 | — | $0 | 272,228 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 122,990 | — | $0 | 122,990 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 122,990 | — | $0 | 122,990 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 149,238 | — | $0 | 272,228 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 260,992 | — | $0 | 533,220 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 260,992 | — | $0 | 533,220 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 407,132 | — | $0 | 940,352 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 407,132 | — | $0 | 940,352 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 1,084,012 | $5.00 | $5.42M | 10,622,957 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 831,978 | $5.00 | $4.16M | 8,153,107 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 2,000,000 | $5.00 | $10.00M | 6,207,982 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 1,084,010 | $5.00 | $5.42M | 10,622,928 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2025-07-31 | 2025-08-04 | 2,599,932 | $3.20 | $8.32M | 7,321,129 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2025-07-31 | 2025-08-04 | 3,387,539 | $3.20 | $10.84M | 9,538,945 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2025-07-31 | 2025-08-04 | 3,387,529 | $3.20 | $10.84M | 9,538,918 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-06-27 | 2025-07-01 | 370,075 | $18.46 | $6.83M | 4,887,254 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-06-27 | 2025-07-01 | 370,074 | $18.46 | $6.83M | 4,887,254 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-11-12 | 2024-11-13 | 9,554 | $17.77 | $169.8K | 5,257,329 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-11-12 | 2024-11-13 | 7,854 | $17.16 | $134.8K | 5,266,881 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-11-12 | 2024-11-13 | 7,853 | $17.16 | $134.8K | 5,266,883 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-11-12 | 2024-11-13 | 9,553 | $17.77 | $169.8K | 5,257,328 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-11-11 | 2024-11-13 | 223,632 | $18.15 | $4.06M | 5,274,735 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-11-11 | 2024-11-13 | 223,632 | $18.15 | $4.06M | 5,274,736 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-11-11 | 2024-11-13 | 40,596 | $17.45 | $708.4K | 5,498,367 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-11-11 | 2024-11-13 | 40,596 | $17.45 | $708.4K | 5,498,368 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2024-02-16 | 2024-02-16 | 1,430,205 | $8.74 | $12.50M | 4,207,982 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2024-02-16 | 2024-02-16 | 1,430,206 | $8.74 | $12.50M | 6,151,389 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2024-02-16 | 2024-02-16 | 1,430,206 | $8.74 | $12.50M | 6,151,406 | SEC↗ |
| GUTS Fractyl Health, Inc. | C Conversion deriv | 2024-02-06 | 2024-02-08 | 1,625,699 | — | $0 | 0 | SEC↗ |
| GUTS Fractyl Health, Inc. | C Conversion deriv | 2024-02-06 | 2024-02-08 | 164,612 | — | $0 | 0 | SEC↗ |
| GUTS Fractyl Health, Inc. | C Conversion | 2024-02-06 | 2024-02-08 | 76,706 | — | $0 | 834,254 | SEC↗ |
| GUTS Fractyl Health, Inc. | C Conversion | 2024-02-06 | 2024-02-08 | 757,548 | — | $0 | 757,548 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-30 | 2022-12-30 | 15,220 | $0.27 | $4.1K | 284,697 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-30 | 2022-12-30 | 61,826 | $0.27 | $16.7K | 1,156,309 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-30 | 2022-12-30 | 61,826 | $0.27 | $16.7K | 1,156,308 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-29 | 2022-12-30 | 63,107 | $0.26 | $16.4K | 1,218,135 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-29 | 2022-12-30 | 63,108 | $0.26 | $16.4K | 1,218,134 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-29 | 2022-12-30 | 15,538 | $0.26 | $4.0K | 299,917 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-28 | 2022-12-30 | 24,757 | $0.25 | $6.2K | 1,281,242 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-28 | 2022-12-30 | 6,096 | $0.25 | $1.5K | 315,455 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-28 | 2022-12-30 | 24,757 | $0.25 | $6.2K | 1,281,242 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-27 | 2022-12-27 | 7,136 | $0.27 | $1.9K | 321,551 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-27 | 2022-12-27 | 28,977 | $0.27 | $7.8K | 1,305,999 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-27 | 2022-12-27 | 28,977 | $0.27 | $7.8K | 1,305,999 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-22 | 2022-12-27 | 3,693 | $0.28 | $1.0K | 1,334,976 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-22 | 2022-12-27 | 3,692 | $0.28 | $1.0K | 1,334,976 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-22 | 2022-12-27 | 909 | $0.28 | $255 | 328,687 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-21 | 2022-12-21 | 6,144 | $0.30 | $1.8K | 1,338,668 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-21 | 2022-12-21 | 6,143 | $0.30 | $1.8K | 1,338,669 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-21 | 2022-12-21 | 1,513 | $0.30 | $454 | 329,596 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-20 | 2022-12-21 | 1,616 | $0.31 | $501 | 331,109 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-20 | 2022-12-21 | 6,562 | $0.31 | $2.0K | 1,344,812 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-20 | 2022-12-21 | 6,562 | $0.31 | $2.0K | 1,344,812 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-19 | 2022-12-21 | 44,394 | $0.29 | $12.9K | 1,351,374 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-19 | 2022-12-21 | 44,394 | $0.29 | $12.9K | 1,351,374 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-19 | 2022-12-21 | 10,930 | $0.29 | $3.2K | 332,725 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-15 | 2022-12-15 | 1,375 | $0.39 | $536 | 1,395,768 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-15 | 2022-12-15 | 339 | $0.39 | $132 | 343,655 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-15 | 2022-12-15 | 1,375 | $0.39 | $536 | 1,395,768 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-14 | 2022-12-15 | 943 | $0.38 | $358 | 343,994 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-14 | 2022-12-15 | 3,829 | $0.38 | $1.5K | 1,397,143 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-14 | 2022-12-15 | 3,828 | $0.38 | $1.5K | 1,397,143 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-13 | 2022-12-15 | 934 | $0.41 | $383 | 1,400,971 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-13 | 2022-12-15 | 933 | $0.41 | $383 | 1,400,972 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-13 | 2022-12-15 | 230 | $0.41 | $94 | 344,937 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2022-09-16 | 2022-09-20 | 2,777,777 | $3.15 | $8.75M | 2,777,777 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2022-09-16 | 2022-09-20 | 2,777,777 | $3.15 | $8.75M | 4,721,197 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2022-09-16 | 2022-09-20 | 2,777,777 | $3.15 | $8.75M | 4,721,183 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2022-09-16 | 2022-09-20 | 2,777,777 | $3.15 | $8.75M | 4,721,200 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award deriv | 2022-06-30 | 2022-07-05 | 1,889,509 | — | $0 | 1,889,509 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award deriv | 2022-06-30 | 2022-07-05 | 1,889,509 | — | $0 | 1,889,509 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2021-07-19 | 2021-07-21 | 390,836 | $14.00 | $5.47M | 1,974,638 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2021-07-19 | 2021-07-21 | 680,592 | $14.00 | $9.53M | 3,438,589 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2021-06-30 | 2021-07-02 | 228,571 | $8.75 | $2.00M | 1,943,423 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2021-06-30 | 2021-07-02 | 228,569 | $8.75 | $2.00M | 1,943,406 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2021-06-30 | 2021-07-02 | 228,570 | $8.75 | $2.00M | 1,943,420 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2021-02-17 | 2021-02-18 | 32,884 | $19.00 | $624.8K | 345,167 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2021-02-17 | 2021-02-18 | 133,558 | $19.00 | $2.54M | 1,401,905 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2021-02-17 | 2021-02-18 | 133,558 | $19.00 | $2.54M | 1,401,905 | SEC↗ |
| LUMO LUMOS PHARMA, INC. | S Sale | 2021-01-08 | 2021-01-08 | 1,000 | $24.11 | $24.1K | 890,080 | SEC↗ |
| LUMO LUMOS PHARMA, INC. | S Sale | 2021-01-08 | 2021-01-08 | 101,600 | $22.24 | $2.26M | 784,568 | SEC↗ |
| LUMO LUMOS PHARMA, INC. | S Sale | 2021-01-08 | 2021-01-08 | 3,912 | $23.57 | $92.2K | 886,168 | SEC↗ |
| LUMO LUMOS PHARMA, INC. | S Sale | 2021-01-07 | 2021-01-08 | 4,378 | $25.05 | $109.7K | 891,080 | SEC↗ |
| LUMO LUMOS PHARMA, INC. | S Sale | 2021-01-07 | 2021-01-08 | 11,794 | $24.35 | $287.2K | 895,458 | SEC↗ |
| LUMO LUMOS PHARMA, INC. | S Sale | 2021-01-06 | 2021-01-08 | 931 | $22.64 | $21.1K | 907,252 | SEC↗ |
| LUMO LUMOS PHARMA, INC. | S Sale | 2021-01-06 | 2021-01-08 | 28,108 | $22.47 | $631.6K | 908,183 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 2,449,761 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 7,499,999 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 7,499,999 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 2,449,761 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 2,449,761 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 202,670 | — | $0 | 823,150 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2020-10-06 | 2020-10-08 | 445,194 | $15.00 | $6.68M | 1,268,344 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2020-10-06 | 2020-10-08 | 445,194 | $15.00 | $6.68M | 1,268,344 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 202,670 | — | $0 | 202,670 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2020-10-06 | 2020-10-08 | 109,612 | $15.00 | $1.64M | 312,282 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 202,670 | — | $0 | 823,150 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 620,480 | — | $0 | 620,480 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 620,480 | — | $0 | 620,480 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 2,624,901 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 2,624,901 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 12,809,912 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 12,809,910 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 2,624,901 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 291,467 | — | $0 | 291,467 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 291,467 | — | $0 | 1,713,873 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | P Buy | 2020-09-29 | 2020-10-01 | 1,562,500 | $16.00 | $25.00M | 1,853,967 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 1,422,406 | — | $0 | 1,422,406 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 1,422,406 | — | $0 | 1,422,406 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 291,467 | — | $0 | 1,713,873 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 449,992 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 1,002,464 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 189,366 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 1,199,980 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion | 2020-08-10 | 2020-08-12 | 1,199,980 | — | $0 | 1,199,980 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2020-08-10 | 2020-08-12 | 944,444 | $18.00 | $17.00M | 1,583,802 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion | 2020-08-10 | 2020-08-12 | 1,002,464 | — | $0 | 2,202,444 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion | 2020-08-10 | 2020-08-12 | 189,366 | — | $0 | 639,358 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2020-08-10 | 2020-08-12 | 555,556 | $18.00 | $10.00M | 2,758,000 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion | 2020-08-10 | 2020-08-12 | 449,992 | — | $0 | 449,992 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award deriv | 2020-08-05 | 2020-08-12 | 12,454 | — | $0 | 12,454 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award | 2020-08-05 | 2020-08-12 | 2,222 | — | $0 | 2,222 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-30 | 2020-01-31 | 509,970 | $15.45 | $7.88M | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-29 | 2020-01-31 | 8,857 | $15.45 | $136.8K | 509,970 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-28 | 2020-01-28 | 65,891 | $15.51 | $1.02M | 518,827 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-27 | 2020-01-28 | 193,359 | $15.77 | $3.05M | 584,718 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-24 | 2020-01-28 | 380,256 | $15.69 | $5.97M | 778,077 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-24 | 2019-12-27 | 198,767 | $21.95 | $4.36M | 2,321,199 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-24 | 2019-12-27 | 151,233 | $21.95 | $3.32M | 1,766,106 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-23 | 2019-12-23 | 56,595 | $21.83 | $1.24M | 1,917,339 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-23 | 2019-12-23 | 74,384 | $21.83 | $1.62M | 2,519,966 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-20 | 2019-12-23 | 9,130 | $21.50 | $196.3K | 1,973,934 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-20 | 2019-12-23 | 11,999 | $21.50 | $258.0K | 2,594,350 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-19 | 2019-12-23 | 5,454 | $21.68 | $118.2K | 1,983,064 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-19 | 2019-12-23 | 7,168 | $21.68 | $155.4K | 2,606,349 | SEC↗ |
| FIXX Homology Medicines, Inc. | P Buy | 2019-04-12 | 2019-04-15 | 533,333 | $22.50 | $12.00M | 1,158,333 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion deriv | 2019-03-11 | 2019-03-11 | 1,619,433 | — | $0 | 0 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion deriv | 2019-03-11 | 2019-03-11 | 284,659 | — | $0 | 0 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion deriv | 2019-03-11 | 2019-03-11 | 1,619,433 | — | $0 | 0 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion deriv | 2019-03-11 | 2019-03-11 | 284,659 | — | $0 | 0 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion | 2019-03-11 | 2019-03-11 | 23,333 | — | $0 | 156,073 | SEC↗ |
| SWAV ShockWave Medical, Inc. | P Buy | 2019-03-11 | 2019-03-11 | 10,000 | $17.00 | $170.0K | 166,073 | SEC↗ |
| SWAV ShockWave Medical, Inc. | P Buy | 2019-03-11 | 2019-03-11 | 10,000 | $17.00 | $170.0K | 166,073 | SEC↗ |
| SWAV ShockWave Medical, Inc. | P Buy | 2019-03-11 | 2019-03-11 | 10,000 | $17.00 | $170.0K | 10,000 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion | 2019-03-11 | 2019-03-11 | 132,740 | — | $0 | 132,740 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion | 2019-03-11 | 2019-03-11 | 23,333 | — | $0 | 156,073 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion | 2019-03-11 | 2019-03-11 | 132,740 | — | $0 | 132,740 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-02-11 | 2019-02-12 | 1,351 | $15.00 | $20.3K | 856,470 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-02-08 | 2019-02-12 | 5,890 | $15.11 | $89.0K | 857,821 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-02-07 | 2019-02-07 | 9,409 | $15.00 | $141.1K | 863,711 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-02-06 | 2019-02-07 | 400 | $15.00 | $6.0K | 873,120 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-02-05 | 2019-02-07 | 4,998 | $15.07 | $75.3K | 873,520 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-01-29 | 2019-01-30 | 6,210 | $15.14 | $94.0K | 878,518 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-01-28 | 2019-01-30 | 828 | $15.00 | $12.4K | 884,728 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-01-25 | 2019-01-25 | 76,820 | $15.08 | $1.16M | 885,556 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-01-24 | 2019-01-25 | 5,425 | $15.03 | $81.5K | 962,376 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-01-23 | 2019-01-25 | 32,199 | $16.35 | $526.5K | 967,801 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion deriv | 2018-10-01 | 2018-10-01 | 998,004 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion deriv | 2018-10-01 | 2018-10-01 | 998,004 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion deriv | 2018-10-01 | 2018-10-01 | 998,004 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion | 2018-10-01 | 2018-10-01 | 307,078 | — | $0 | 307,078 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion | 2018-10-01 | 2018-10-01 | 307,078 | — | $0 | 307,078 | SEC↗ |
| ARVN ARVINAS INC. | P Buy | 2018-10-01 | 2018-10-01 | 104,167 | $16.00 | $1.67M | 411,245 | SEC↗ |
| ARVN ARVINAS INC. | P Buy | 2018-10-01 | 2018-10-01 | 104,167 | $16.00 | $1.67M | 411,245 | SEC↗ |
| ARVN ARVINAS INC. | P Buy | 2018-10-01 | 2018-10-01 | 104,166 | $16.00 | $1.67M | 411,244 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion | 2018-10-01 | 2018-10-01 | 307,078 | — | $0 | 307,078 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion deriv | 2018-06-25 | 2018-06-27 | 1,557,292 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion deriv | 2018-06-25 | 2018-06-27 | 1,557,292 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2018-06-25 | 2018-06-27 | 624,333 | $15.00 | $9.36M | 1,498,666 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion | 2018-06-25 | 2018-06-27 | 874,333 | — | $0 | 874,333 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion | 2018-06-25 | 2018-06-27 | 874,333 | — | $0 | 874,333 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2018-06-25 | 2018-06-27 | 125,667 | $15.00 | $1.89M | 1,000,000 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 6,944,444 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 6,944,445 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 3,521,126 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 3,521,126 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 669,034 | — | $0 | 669,034 | SEC↗ |
| FIXX Homology Medicines, Inc. | P Buy | 2018-04-02 | 2018-04-04 | 625,000 | $16.00 | $10.00M | 625,000 | SEC↗ |
| FIXX Homology Medicines, Inc. | P Buy | 2018-04-02 | 2018-04-04 | 625,000 | $16.00 | $10.00M | 2,613,517 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 669,034 | — | $0 | 669,034 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 1,319,483 | — | $0 | 1,988,517 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 1,319,484 | — | $0 | 1,988,518 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-10 | 2,668,518 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-10 | 2,668,518 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | P Buy | 2017-10-10 | 2017-10-10 | 177,500 | $17.00 | $3.02M | 468,505 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-10 | 291,005 | — | $0 | 291,005 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-10 | 291,005 | — | $0 | 291,005 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | P Buy | 2017-10-10 | 2017-10-10 | 177,500 | $17.00 | $3.02M | 468,505 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 267,998 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 535,996 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 99,830 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 99,830 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 267,998 | — | $0 | 267,998 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 535,996 | — | $0 | 535,996 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 99,830 | — | $0 | 635,826 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | P Buy | 2016-07-25 | 2016-07-25 | 253,404 | $15.00 | $3.80M | 889,230 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | P Buy | 2016-07-25 | 2016-07-25 | 146,596 | $15.00 | $2.20M | 514,424 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 99,830 | — | $0 | 367,828 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-06 | 508,566 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-06 | 1,186,654 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2016-07-06 | 2016-07-06 | 120,000 | $12.50 | $1.50M | 628,566 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2016-07-06 | 2016-07-06 | 280,000 | $12.50 | $3.50M | 1,466,654 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-06 | 508,566 | — | $0 | 508,566 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-06 | 1,186,654 | — | $0 | 1,186,654 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 1,182,941 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 117,998 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 117,996 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 67,448 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | P Buy | 2016-02-17 | 2016-02-19 | 122,793 | $20.00 | $2.46M | 1,623,089 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion | 2016-02-17 | 2016-02-19 | 117,998 | — | $0 | 249,909 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion | 2016-02-17 | 2016-02-19 | 117,996 | — | $0 | 1,500,296 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion | 2016-02-17 | 2016-02-19 | 1,182,941 | — | $0 | 1,382,300 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion | 2016-02-17 | 2016-02-19 | 67,448 | — | $0 | 199,359 | SEC↗ |
| AVXS AveXis, Inc. | P Buy | 2016-02-17 | 2016-02-19 | 112,000 | $20.00 | $2.24M | 112,000 | SEC↗ |
| AVXS AveXis, Inc. | P Buy | 2016-02-17 | 2016-02-19 | 88,000 | $20.00 | $1.76M | 88,000 | SEC↗ |
| AVXS AveXis, Inc. | P Buy | 2016-02-17 | 2016-02-19 | 163,702 | $20.00 | $3.27M | 413,611 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-08 | 854,700 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-08 | 854,700 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2016-02-08 | 2016-02-08 | 100,000 | $16.00 | $1.60M | 954,700 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2016-02-08 | 2016-02-08 | 854,700 | — | $0 | 854,700 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2016-02-08 | 2016-02-08 | 854,700 | — | $0 | 854,700 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-08 | 2015-12-08 | 27,530 | $3.04 | $83.7K | 728,718 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-08 | 2015-12-08 | 27,529 | $3.04 | $83.7K | 4,760,408 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-07 | 2015-12-08 | 68,294 | $3.00 | $204.9K | 4,732,879 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-07 | 2015-12-08 | 68,294 | $3.00 | $204.9K | 701,188 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-04 | 2015-12-08 | 40,301 | $3.01 | $121.3K | 632,894 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-04 | 2015-12-08 | 40,301 | $3.01 | $121.3K | 4,664,585 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-03 | 2015-12-03 | 53,486 | $3.00 | $160.5K | 4,624,284 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-03 | 2015-12-03 | 53,487 | $3.00 | $160.5K | 592,593 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-02 | 2015-12-03 | 55,257 | $2.98 | $164.7K | 539,106 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-02 | 2015-12-03 | 55,257 | $2.98 | $164.7K | 4,570,798 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-01 | 2015-12-03 | 12,882 | $3.05 | $39.3K | 483,849 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-01 | 2015-12-03 | 12,883 | $3.05 | $39.3K | 4,515,541 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-11-06 | 2015-11-10 | 36,625 | $2.98 | $109.1K | 470,967 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-11-06 | 2015-11-10 | 36,625 | $2.98 | $109.1K | 4,502,658 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-30 | 2015-11-03 | 8,271 | $3.00 | $24.8K | 4,466,033 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-30 | 2015-11-03 | 8,271 | $3.00 | $24.8K | 434,342 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-28 | 2015-10-29 | 13,165 | $2.99 | $39.4K | 426,071 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-28 | 2015-10-29 | 13,165 | $2.99 | $39.4K | 4,457,762 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-27 | 2015-10-29 | 16,506 | $3.00 | $49.5K | 412,906 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-27 | 2015-10-29 | 16,506 | $3.00 | $49.5K | 4,444,597 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-26 | 2015-10-26 | 17,117 | $3.00 | $51.4K | 396,400 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-26 | 2015-10-26 | 17,116 | $3.00 | $51.3K | 4,428,091 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-23 | 2015-10-26 | 12,091 | $3.00 | $36.3K | 4,410,975 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-23 | 2015-10-26 | 12,090 | $3.00 | $36.3K | 379,283 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-22 | 2015-10-26 | 975 | $3.00 | $2.9K | 4,398,884 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-22 | 2015-10-26 | 975 | $3.00 | $2.9K | 367,193 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-21 | 2015-10-21 | 80,342 | $3.00 | $241.0K | 366,218 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-21 | 2015-10-21 | 80,342 | $3.00 | $241.0K | 4,397,909 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-20 | 2015-10-21 | 50,065 | $3.00 | $150.2K | 4,317,567 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-20 | 2015-10-21 | 50,065 | $3.00 | $150.2K | 285,876 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-19 | 2015-10-21 | 64,613 | $2.92 | $188.7K | 4,267,502 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-19 | 2015-10-21 | 64,613 | $2.92 | $188.7K | 235,811 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion deriv | 2015-10-14 | 2015-10-14 | 160,512 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion deriv | 2015-10-14 | 2015-10-14 | 160,512 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion | 2015-10-14 | 2015-10-14 | 160,512 | — | $0 | 160,512 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | P Buy | 2015-10-14 | 2015-10-14 | 114,488 | $12.00 | $1.37M | 275,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion | 2015-10-14 | 2015-10-14 | 160,512 | — | $0 | 160,512 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | P Buy | 2015-10-14 | 2015-10-14 | 510,512 | $12.00 | $6.13M | 671,024 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-09 | 2015-10-09 | 71,540 | $2.53 | $181.0K | 171,198 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-09 | 2015-10-09 | 71,540 | $2.53 | $181.0K | 4,202,889 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-08 | 2015-10-09 | 19,817 | $2.50 | $49.5K | 99,658 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-08 | 2015-10-09 | 19,816 | $2.50 | $49.5K | 4,131,349 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-07 | 2015-10-09 | 69,536 | $2.30 | $159.9K | 79,841 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-07 | 2015-10-09 | 69,536 | $2.30 | $159.9K | 4,111,533 | SEC↗ |
| RGNX REGENXBIO Inc. | C Conversion deriv | 2015-09-22 | 2015-09-22 | 771,963 | — | $0 | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | C Conversion deriv | 2015-09-22 | 2015-09-22 | 397,079 | — | $0 | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | C Conversion | 2015-09-22 | 2015-09-22 | 771,963 | — | $0 | 771,963 | SEC↗ |
| RGNX REGENXBIO Inc. | C Conversion | 2015-09-22 | 2015-09-22 | 397,079 | — | $0 | 1,169,042 | SEC↗ |
| RGNX REGENXBIO Inc. | P Buy | 2015-09-22 | 2015-09-22 | 87,500 | $22.00 | $1.93M | 1,256,542 | SEC↗ |
| RGNX REGENXBIO Inc. | P Buy | 2015-09-22 | 2015-09-22 | 38,500 | $22.00 | $847.0K | 38,500 | SEC↗ |
| RGNX REGENXBIO Inc. | P Buy | 2015-09-22 | 2015-09-22 | 49,000 | $22.00 | $1.08M | 49,000 | SEC↗ |
| AVXS AveXis, Inc. | P Buy deriv | 2015-09-03 | 2016-02-19 | 117,996 | $21.01 | $2.48M | 0 | SEC↗ |
| AVXS AveXis, Inc. | P Buy deriv | 2015-09-03 | 2016-02-19 | 117,998 | $21.01 | $2.48M | 0 | SEC↗ |
| AVXS AveXis, Inc. | P Buy | 2015-09-03 | 2016-02-19 | 131,911 | $18.48 | $2.44M | 131,911 | SEC↗ |
| AVXS AveXis, Inc. | P Buy | 2015-09-03 | 2016-02-19 | 131,911 | $18.48 | $2.44M | 131,911 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | X Exercise deriv | 2015-07-28 | 2015-07-28 | 104,166 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | X Exercise deriv | 2015-07-28 | 2015-07-28 | 104,166 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion deriv | 2015-07-28 | 2015-07-28 | 500,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion deriv | 2015-07-28 | 2015-07-28 | 500,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | X Exercise | 2015-07-28 | 2015-07-28 | 104,166 | $12.00 | $1.25M | 312,499 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | P Buy | 2015-07-28 | 2015-07-28 | 200,000 | $15.00 | $3.00M | 429,166 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion | 2015-07-28 | 2015-07-28 | 208,333 | — | $0 | 208,333 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | P Buy | 2015-07-28 | 2015-07-28 | 200,000 | $15.00 | $3.00M | 429,166 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | X Exercise | 2015-07-28 | 2015-07-28 | 104,166 | $12.00 | $1.25M | 312,499 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2015-07-28 | 2015-07-28 | 83,333 | $15.00 | $1.25M | 229,166 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | S Sale | 2015-07-28 | 2015-07-28 | 83,333 | $15.00 | $1.25M | 229,166 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | C Conversion | 2015-07-28 | 2015-07-28 | 208,333 | — | $0 | 208,333 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-13 | 2,234,137 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-13 | 2,234,137 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2015-05-12 | 2015-05-13 | 25,000 | $14.00 | $350.0K | 255,764 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-13 | 230,764 | — | $0 | 230,764 | SEC↗ |